心脏肿瘤学临床试验的多样性：操作方法
Diversity in Cardio-Oncology Clinical Trials: How To.
作者信息
Martei Yehoda M, Afari Henrietta A, Guerra Carmen E
机构信息
Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
JACC CardioOncol. 2024 Jun 18;6(3):386-389. doi: 10.1016/j.jaccao.2024.03.012. eCollection 2024 Jun.
Abstract
•Intersectionality of health inequities in CVD and cancer may compound inequities in cardio-oncology.•Equitable access to clinical trials is 1 of many key strategies to mitigate these health disparities.•Cardio-oncology trials should collect and report the race and ethnicity of participants, including disaggregate data on smaller minority groups.•Successful interventions consist of multilevel strategies targeting structural-, clinical-, provider-, and patient-level barriers.
摘要
•心血管疾病（CVD）和癌症中健康不平等的交叉性可能会加剧心脏肿瘤学中的不平等。
•公平参与临床试验是减轻这些健康差距的众多关键策略之一。
•心脏肿瘤学试验应收集并报告参与者的种族和族裔信息，包括较小少数群体的分类数据。
•成功的干预措施包括针对结构、临床、医疗服务提供者和患者层面障碍的多层次策略。
相似文献
1
Diversity in Cardio-Oncology Clinical Trials: How To.心脏肿瘤学临床试验的多样性：操作方法
JACC CardioOncol. 2024 Jun 18;6(3):386-389. doi: 10.1016/j.jaccao.2024.03.012. eCollection 2024 Jun.
2
Social Determinants of Health in Cardio-Oncology: Multi-Level Strategies to Overcome Disparities in Care: State-of-the-Art Review.心脏肿瘤学中的健康社会决定因素：克服医疗差异的多层次策略：最新综述
JACC CardioOncol. 2024 May 7;6(3):331-346. doi: 10.1016/j.jaccao.2024.02.009. eCollection 2024 Jun.
3
Health Literacy, Individual and Community Engagement, and Cardiovascular Risks and Disparities: State-of-the-Art Review.健康素养、个体与社区参与以及心血管风险与差异：最新综述
JACC CardioOncol. 2024 May 7;6(3):363-380. doi: 10.1016/j.jaccao.2024.03.010. eCollection 2024 Jun.
4
Community Engagement to Advance Equitable Cardio-Oncology Care: A Call to Action: How To.社区参与促进公平的心脏肿瘤护理：行动呼吁：如何做。
JACC CardioOncol. 2024 Jun 18;6(3):381-385. doi: 10.1016/j.jaccao.2024.05.002. eCollection 2024 Jun.
5
Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: How To.建立临床心脏肿瘤学项目及成功要素：操作指南
JACC CardioOncol. 2023 Aug 8;5(5):707-710. doi: 10.1016/j.jaccao.2023.06.002. eCollection 2023 Oct.
6
Disparities in Clinical Trial Participation: Multilevel Opportunities for Improvement.临床试验参与中的差异：多层次的改进机会。
Surg Oncol Clin N Am. 2022 Jan;31(1):55-64. doi: 10.1016/j.soc.2021.07.007. Epub 2021 Oct 19.
7
Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations.心脏肿瘤学护理提供中的不公平现象：剖析弱势群体中的差异。
Front Oncol. 2023 Jun 9;13:1124447. doi: 10.3389/fonc.2023.1124447. eCollection 2023.
8
Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: State-of-the-Art Review.心脏肿瘤学基础与转化科学的优先事项：GCOS 2023研讨会论文集：最新综述
JACC CardioOncol. 2023 Sep 27;5(6):715-731. doi: 10.1016/j.jaccao.2023.08.003. eCollection 2023 Dec.
9
Air Pollution in Cardio-Oncology and Unraveling the Environmental Nexus: : State-of-the-Art Review.心血管肿瘤学中的空气污染与揭示环境关联：最新综述
JACC CardioOncol. 2024 Jun 18;6(3):347-362. doi: 10.1016/j.jaccao.2024.04.003. eCollection 2024 Jun.
10
Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement.心脏肿瘤学中的差异：对结果的影响和改善机会。
Curr Cardiol Rep. 2022 Sep;24(9):1117-1127. doi: 10.1007/s11886-022-01732-2. Epub 2022 Jun 27.
引用本文的文献
1
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer.肿瘤学临床试验中的心血管安全性：《美国心脏病学会杂志：心血管肿瘤学入门》
JACC CardioOncol. 2025 Feb;7(2):83-95. doi: 10.1016/j.jaccao.2024.09.014. Epub 2024 Dec 10.
本文引用的文献
1
Strategies to Advance Equity in Cancer Clinical Trials.推进癌症临床试验公平性的策略。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-11. doi: 10.1200/EDBK_350565.
2
A Scoping Review of Strategies to Increase Black Enrollment and Retention in Cancer Clinical Trials.增加癌症临床试验中黑人入组和保留率的策略：范围综述
JCO Oncol Pract. 2022 Sep;18(9):614-632. doi: 10.1200/OP.21.00863. Epub 2022 Jun 7.
3
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: State-of-the-Art Review.心脏保护在癌症治疗中的作用：心脏毒性——最新综述
JACC CardioOncol. 2022 Mar 15;4(1):19-37. doi: 10.1016/j.jaccao.2022.01.101. eCollection 2022 Mar.
4
Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020.2006-2020 年美国食品药品监督管理局批准的 24 种心血管药物临床试验中黑人美国居民的参与情况。
JAMA Netw Open. 2021 Mar 1;4(3):e212640. doi: 10.1001/jamanetworkopen.2021.2640.
5
Twenty Years of Leading the Way among Cohort Studies in Community-Driven Outreach and Engagement: Jackson State University/Jackson Heart Study.20 年引领社区驱动外展和参与队列研究：杰克逊州立大学/杰克逊心脏研究。
Int J Environ Res Public Health. 2021 Jan 15;18(2):696. doi: 10.3390/ijerph18020696.
6
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.“被邀请参与时”：关于患者同意参与癌症临床试验的系统评价与荟萃分析
J Natl Cancer Inst. 2021 Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
7
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.系统评价和荟萃分析癌症临床试验参与的结构、临床以及医生和患者障碍的程度。
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.
8
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer.FDA 批准概要：帕妥珠单抗用于辅助治疗人表皮生长因子受体 2 阳性早期乳腺癌。
Clin Cancer Res. 2019 May 15;25(10):2949-2955. doi: 10.1158/1078-0432.CCR-18-3003. Epub 2018 Dec 14.
9
A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.一项在黑人理发店开展的血压降低群组随机试验。
N Engl J Med. 2018 Apr 5;378(14):1291-1301. doi: 10.1056/NEJMoa1717250. Epub 2018 Mar 12.
Zotero 插件